Akebia Therapeutics, Inc.

{
  "main_header": {
    "sid": 1149959,
    "name": "Akebia Therapeutics, Inc.",
    "stock_name": "Akebia Therapeutics, Inc.",
    "full_name": "Akebia Therapeutics, Inc.",
    "name_url": "stocks-analysis/akebia-therapeutics-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.39",
    "chg": -2.44,
    "chgp": "-63.71%",
    "dir": -1,
    "prev_price": "3.83",
    "mcapval": "363.55",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US00972D1054",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "6.84 M",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/akebia-therapeutics-inc-1149959-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Akebia Therapeutics Hits New 52-Week Low at $1.49",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/akebia-therapeutics-hits-new-52-week-low-at-149-3726080",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AkebiaTherapeut_priceRelatedfactors_3726080.png",
        "date": "2025-11-24 16:21:09",
        "description": "Akebia Therapeutics, Inc. has reached a new 52-week low, reflecting ongoing challenges in a competitive market. The company has reported a decline in net sales and negative return on equity, despite achieving a recent quarterly sales high. Institutional holdings remain significant, indicating some investor confidence amid financial difficulties."
      }
    ],
    "total": 10,
    "sid": "1149959",
    "stock_news_url": "https://www.marketsmojo.com/news/akebia-therapeutics-inc-1149959"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Akebia Therapeutics Hits New 52-Week Low at $1.49

2025-11-24 16:21:09

Akebia Therapeutics, Inc. has reached a new 52-week low, reflecting ongoing challenges in a competitive market. The company has reported a decline in net sales and negative return on equity, despite achieving a recent quarterly sales high. Institutional holdings remain significant, indicating some investor confidence amid financial difficulties.

Read full news article

View All News